Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program focuses on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, Deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. The clinical development program for Deramiocel has focused primarily on adolescents and young adults with DMD, including many patients who are non-ambulatory and experiencing progressive cardiac and skeletal muscle decline. Its StealthX exosome platform program consists of engineered exosomes for vaccine and therapeutic development. The StealthX vaccine is a proprietary vaccine developed internally utilizing exosomes that were engineered to express either spike or nucleocapsid proteins on the surface.
Find out what a historical investment in Capricor Therapeutics Inc would be worth today using our CAPR stock calculator.
Buying CAPR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Capricor Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in CAPR
What is the ticker symbol of Capricor Therapeutics Inc?
The ticker symbol for Capricor Therapeutics Inc is CAPR.
How much is one share of CAPR?
One share of CAPR is valued at $7.53 as of 20 November 2026.
What is the market capitalisation of Capricor Therapeutics Inc CAPR?
As of 20 November 2026 Capricor Therapeutics Inc has a market cap of $466.88M.
What is the 52-week high for Capricor Therapeutics Inc stock?
The Capricor Therapeutics Inc 52-week high stock price is $40.37.
What is the 52-week low for Capricor Therapeutics Inc stock?
The Capricor Therapeutics Inc 52-week low stock price is $2.96.
Can I buy CAPR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CAPR shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CAPR on Stake
Buy CAPR from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of CAPR from only US$10 with fractional shares